A Game-based Neurodevelopmental Assessment for Young Children
NCT ID: NCT05780853
Last Updated: 2024-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
590 participants
OBSERVATIONAL
2023-01-30
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool.
The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
All participants will complete the tablet game-based assessment which aims to assess a range of neuropsychological functions including attention, memory, language, motor, executive functions and social-emotional skills. Parents/carers of participants will also complete a demographic questionnaire and the Adaptive Behaviour System - Third Edition (ABAS-3), which is a questionnaire that assesses a child's development. Some participants will be re-tested on the tablet game-based assessment approximately 2 weeks after the first tablet game-based assessment to ensure the game's validity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor Learning and Brain Changes in Autism
NCT02358317
Modeling and Testing Change in Mental Abilities in Childhood
NCT02459873
Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders
NCT04308915
Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD
NCT02618135
Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills
NCT04518358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Typically Developing Children (Control Group)
Typically developing children with no known neurodevelopmental disorder, medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.
Tablet Game-based Assessment - YARN assessment service
Tablet game-based assessment to assess neurodevelopmental profile.
Adaptive Behavior Assessment System, Third Edition (ABAS-3)
A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.
Demographic questionnaire
Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.
Children with a Diagnosed Neurodevelopmental Disorder (Clinical Group)
Children with a diagnosed neurodevelopmental disorder including: Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. Children must also have no known medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.
Tablet Game-based Assessment - YARN assessment service
Tablet game-based assessment to assess neurodevelopmental profile.
Adaptive Behavior Assessment System, Third Edition (ABAS-3)
A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.
Demographic questionnaire
Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tablet Game-based Assessment - YARN assessment service
Tablet game-based assessment to assess neurodevelopmental profile.
Adaptive Behavior Assessment System, Third Edition (ABAS-3)
A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.
Demographic questionnaire
Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
OR
* 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.
Exclusion Criteria
3 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brightlobe Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Iles, PhD DClinPsy
Role: PRINCIPAL_INVESTIGATOR
Brightlobe Limited
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brightlobe Limited
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRIGHTEN-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.